Invesco

Invesco Portfolio holdings

AUM $588B
1-Year Return 25.92%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Quarter Return
+3.8%
1 Year Return
+25.92%
3 Year Return
+99.18%
5 Year Return
+189.75%
10 Year Return
+417.35%
AUM
$541B
AUM Growth
+$22.9B
Cap. Flow
+$18.2B
Cap. Flow %
3.36%
Top 10 Hldgs %
18.96%
Holding
3,869
New
120
Increased
2,140
Reduced
1,371
Closed
106

Sector Composition

1 Technology 25.45%
2 Financials 12.86%
3 Industrials 11.53%
4 Consumer Discretionary 10.57%
5 Healthcare 9.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EWH icon
3426
iShares MSCI Hong Kong ETF
EWH
$724M
$181K ﹤0.01%
10,881
+339
+3% +$5.65K
CX icon
3427
Cemex
CX
$13.6B
$181K ﹤0.01%
32,132
-16,376
-34% -$92.4K
FATE icon
3428
Fate Therapeutics
FATE
$113M
$180K ﹤0.01%
108,934
+7,056
+7% +$11.6K
FUND
3429
Sprott Focus Trust
FUND
$246M
$178K ﹤0.01%
24,276
+555
+2% +$4.06K
NXE icon
3430
NexGen Energy
NXE
$4.48B
$174K ﹤0.01%
26,399
+1,656
+7% +$10.9K
AQST icon
3431
Aquestive Therapeutics
AQST
$602M
$171K ﹤0.01%
47,944
-738,635
-94% -$2.63M
XFLT
3432
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$427M
$170K ﹤0.01%
25,620
-58,148
-69% -$386K
MNTK icon
3433
Montauk Renewables
MNTK
$285M
$169K ﹤0.01%
42,533
-3,258
-7% -$13K
IBRX icon
3434
ImmunityBio
IBRX
$2.43B
$168K ﹤0.01%
65,696
+2,911
+5% +$7.45K
STEM icon
3435
Stem
STEM
$116M
$166K ﹤0.01%
13,790
+229
+2% +$2.76K
ZYXI icon
3436
Zynex
ZYXI
$45.4M
$166K ﹤0.01%
20,756
+552
+3% +$4.42K
CTEV
3437
Claritev Corporation
CTEV
$1.19B
$166K ﹤0.01%
11,218
-81
-0.7% -$1.2K
CRGX
3438
DELISTED
CARGO Therapeutics
CRGX
$165K ﹤0.01%
+11,448
New +$165K
QXO
3439
QXO Inc
QXO
$14.5B
$164K ﹤0.01%
+10,319
New +$164K
ANNX icon
3440
Annexon
ANNX
$233M
$164K ﹤0.01%
31,881
+10,611
+50% +$54.4K
IMMR icon
3441
Immersion
IMMR
$225M
$163K ﹤0.01%
18,621
-4,642
-20% -$40.5K
CDXS icon
3442
Codexis
CDXS
$221M
$161K ﹤0.01%
33,731
+427
+1% +$2.04K
ATXS icon
3443
Astria Therapeutics
ATXS
$425M
$161K ﹤0.01%
17,992
-296,814
-94% -$2.65M
NAGE
3444
Niagen Bioscience, Inc. Common Stock
NAGE
$748M
$160K ﹤0.01%
30,228
-6,481
-18% -$34.4K
GDRX icon
3445
GoodRx Holdings
GDRX
$1.43B
$160K ﹤0.01%
34,459
-722
-2% -$3.36K
NINE icon
3446
Nine Energy Service
NINE
$29.9M
$159K ﹤0.01%
142,284
-918
-0.6% -$1.03K
EB icon
3447
Eventbrite
EB
$263M
$159K ﹤0.01%
47,255
-3,249
-6% -$10.9K
KLXE icon
3448
KLX Energy Services
KLXE
$32.8M
$158K ﹤0.01%
31,784
-200
-0.6% -$996
FDMT icon
3449
4D Molecular Therapeutics
FDMT
$326M
$157K ﹤0.01%
28,157
+732
+3% +$4.08K
HUMA icon
3450
Humacyte
HUMA
$238M
$156K ﹤0.01%
30,927
+1,438
+5% +$7.26K